In this application are described chimeric humanized affinity matured stability enhanced and bispecific Anti GD2 antibodies and fragments thereof. Also provided are methods of using individual antibodies or compositions thereof for the detection prevention and/or therapeutical treatment of GD2 related diseases in particular neuroblastoma.